InsidersTradesSigma
Explore the complete record of transactions filed by Greenhalgh Ellis Skott, Chief Technology Officer. Director active across 1 company, notably TELA Bio, Inc.. Cumulatively, 2 reports have been published. History available since 23 February 2022. The latest transaction was filed on 24 February 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations
Ellis Skott Greenhalgh serves as Chief Technology Officer at TELA Bio, Inc. He oversees the company's technological initiatives, contributing to innovation and product improvement. His role is essential in ensuring the company remains at the forefront of technological advancements in the sector. With his expertise, TELA Bio continues to develop innovative solutions.